Experience of Patients with Diabetes and Other Cardiovascular Risk Factors with Health Professionals and Healthcare in Spain
- PMID: 34206918
- PMCID: PMC8267612
- DOI: 10.3390/jcm10132831
Experience of Patients with Diabetes and Other Cardiovascular Risk Factors with Health Professionals and Healthcare in Spain
Abstract
We aimed to evaluate the experience of patients with type 2 diabetes (T2DM) with healthcare received in Spain. This was a retrospective, observational study in patients with T2DM cared for in primary healthcare (PHC) centers. A cross-sectional analysis of the patients' experience data was performed using the Instrument for the Evaluation of the Experience of Chronic Patients (IEXPAC). A total of 475 patients with T2DM were recruited from 36 PHC centers, of which 248 (52.2%) completed the IEXPAC questionnaire. The IEXPAC total mean score (range 0-10) was 7 points, with an average "new relational model" score of 2.5 points. The mean continuity of care score after hospital discharge was 6.2 points. The results showed that 8% of the patients always or almost always used the internet to check their medical history, appointments or other data from their healthcare service, and 15% responded that healthcare professionals always or almost always informed them of forums or other reliable internet sites to obtain information about their illness. The study results show that there is a wide margin for improvement in the experience of patients with T2DM with healthcare in Spain, especially regarding the information patients receive or can obtain.
Keywords: healthcare; new technologies in primary healthcare; patient experience; type 2 diabetes mellitus.
Conflict of interest statement
DOB received fees for lectures and speaking participation from MSD, Sanofi, Novartis, NovoNordisk, AstraZeneca and Lilly and has served as a consultant to Sanofi. SCS received fees for lectures, participation in presentations and the development of educational presentations from MSD, Boehringer-Ingelheim, Almirall, Bristol Myers, Pfizer, Sanofi and AstraZeneca. JES received consulting fees from MSD and Sanofi and for the development of educational presentations from MSD, Sanofi, Ferrer, Novartis, Lilly, Boehringer-Ingelheim and Menarini. AGG, KFC, MCH and GF are full-time employees at MSD Spain. FLS declared no conflict of interest in relation to this manuscript.
Figures
References
-
- Buttorff C., Ruder T. Multiple Chronic Conditions in the United States. RAND Coorporation; Santa Monica, CA, USA: 2017.
-
- van der Heide I., Snoeijs S., Melchiorre M.G., Quattrini S., Boerma W., Schellevis F., Rijken M. Innovating Care for People with Multiple Chronic Conditions in Europe. NIVEL (Netherlands Institute for Health Services Research); Utrecht, The Netherlands: 2015.
